GlassScriptPhysician profile
Kent A Meldrum
NPI 1205900479
$557.31
in general payments reported to CMS, 2019-2025
15 companies · $72.28 in 2025
The $72.28 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $29.65 · 2021: $57.75 · 2022: $88.80 · 2023: $123 · 2024: $53.67 · 2025: $72.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $94.71 | 2019 | |
| Coopersurgical, INC. | $78.49 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Abbvie INC. | $64.17 | 2019-2023 | |
| Organon LLC | $56.81 | 2022-2025 | Nexplanon |
| Pfizer INC. | $45.96 | 2021-2023 | |
| Sage Therapeutics, LLC | $41.28 | 2023-2024 | |
| Exeltis, USA INC. | $34.05 | 2022-2024 | Slynd |
| Astellas Pharma US INC | $23.15 | 2023 | Veozah |
| Therapeuticsmd, INC. | $20.36 | 2022 | |
| Becton, Dickinson and Company | $19.43 | 2019 | |
| Meditrina | $17.86 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.76 | 2025 | |
| Hologic Sales and Service, LLC | $15.06 | 2020 | |
| Sumitomo Pharma America, INC. | $14.63 | 2025 | Myfembree |
| Amag Pharmaceuticals, INC. | $14.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Meldrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.